135 related articles for article (PubMed ID: 21584293)
1. Anticancer gold(I)-phosphine complexes as potent autophagy-inducing agents.
Tian S; Siu FM; Kui SC; Lok CN; Che CM
Chem Commun (Camb); 2011 Sep; 47(33):9318-20. PubMed ID: 21584293
[TBL] [Abstract][Full Text] [Related]
2. Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.
Vergara E; Casini A; Sorrentino F; Zava O; Cerrada E; Rigobello MP; Bindoli A; Laguna M; Dyson PJ
ChemMedChem; 2010 Jan; 5(1):96-102. PubMed ID: 19937669
[TBL] [Abstract][Full Text] [Related]
3. Novel phosphine sulphide gold(i) complexes: topoisomerase I inhibitors and antiproliferative agents.
Martín-Encinas E; Conejo-Rodríguez V; Miguel JA; Martínez-Ilarduya JM; Rubiales G; Knudsen BR; Palacios F; Alonso C
Dalton Trans; 2020 Jun; 49(23):7852-7861. PubMed ID: 32463416
[TBL] [Abstract][Full Text] [Related]
4. Gold-phosphine-porphyrin as potential metal-based theranostics.
Tasan S; Licona C; Doulain PE; Michelin C; Gros CP; Le Gendre P; Harvey PD; Paul C; Gaiddon C; Bodio E
J Biol Inorg Chem; 2015 Jan; 20(1):143-154. PubMed ID: 25476859
[TBL] [Abstract][Full Text] [Related]
5. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
6. On the biological properties of alkynyl phosphine gold(I) complexes.
Meyer A; Bagowski CP; Kokoschka M; Stefanopoulou M; Alborzinia H; Can S; Vlecken DH; Sheldrick WS; Wölfl S; Ott I
Angew Chem Int Ed Engl; 2012 Aug; 51(35):8895-9. PubMed ID: 22848030
[No Abstract] [Full Text] [Related]
7. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
Ronconi L; Fregona D
Dalton Trans; 2009 Dec; (48):10670-80. PubMed ID: 20023894
[TBL] [Abstract][Full Text] [Related]
8. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
9. A soluble bis-chelated gold(I) diphosphine compound with strong anticancer activity and low toxicity.
Wang Y; Liu M; Cao R; Zhang W; Yin M; Xiao X; Liu Q; Huang N
J Med Chem; 2013 Feb; 56(4):1455-66. PubMed ID: 23362983
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA.
Yilmaz VT; Icsel C; Turgut OR; Aygun M; Erkisa M; Turkdemir MH; Ulukaya E
Eur J Med Chem; 2018 Jul; 155():609-622. PubMed ID: 29920455
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.
Gandin V; Tisato F; Dolmella A; Pellei M; Santini C; Giorgetti M; Marzano C; Porchia M
J Med Chem; 2014 Jun; 57(11):4745-60. PubMed ID: 24793739
[TBL] [Abstract][Full Text] [Related]
12. Highly cytotoxic bioconjugated gold(I) complexes with cysteine-containing dipeptides.
Gutiérrez A; Marzo I; Cativiela C; Laguna A; Gimeno MC
Chemistry; 2015 Jul; 21(31):11088-95. PubMed ID: 26111275
[TBL] [Abstract][Full Text] [Related]
13. Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis.
Tan C; Lai S; Wu S; Hu S; Zhou L; Chen Y; Wang M; Zhu Y; Lian W; Peng W; Ji L; Xu A
J Med Chem; 2010 Nov; 53(21):7613-24. PubMed ID: 20958054
[TBL] [Abstract][Full Text] [Related]
14. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological studies of some gold(I) complexes containing functionalised alkynes.
Schuh E; Valiahdi SM; Jakupec MA; Keppler BK; Chiba P; Mohr F
Dalton Trans; 2009 Dec; (48):10841-5. PubMed ID: 20023914
[TBL] [Abstract][Full Text] [Related]
16. Gold(I) thiolates containing amino acid moieties. Cytotoxicity and structure-activity relationship studies.
Gutiérrez A; Gracia-Fleta L; Marzo I; Cativiela C; Laguna A; Gimeno MC
Dalton Trans; 2014 Dec; 43(45):17054-66. PubMed ID: 25302929
[TBL] [Abstract][Full Text] [Related]
17. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
18. Rapid Synthesis and Antiproliferative Properties of Polyazamacrocycle-Based Bi- and Tetra-Gold(I) Phosphine Dithiocarbamate Complexes.
Florès O; Velic D; Mabrouk N; Bettaïeb A; Tomasoni C; Robert JM; Paul C; Goze C; Roussakis C; Bodio E
Chembiochem; 2019 Sep; 20(17):2255-2261. PubMed ID: 30969460
[TBL] [Abstract][Full Text] [Related]
19. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.
Santini C; Pellei M; Papini G; Morresi B; Galassi R; Ricci S; Tisato F; Porchia M; Rigobello MP; Gandin V; Marzano C
J Inorg Biochem; 2011 Feb; 105(2):232-40. PubMed ID: 21194623
[TBL] [Abstract][Full Text] [Related]
20. Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs.
Bagowski CP; You Y; Scheffler H; Vlecken DH; Schmitz DJ; Ott I
Dalton Trans; 2009 Dec; (48):10799-805. PubMed ID: 20023909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
